-
Mashup Score: 3Ophthalmology Management - INDUSTRY INSIDER - 2 year(s) ago
AURION BIOTECH’S GREG KUNST
Source: Ophthalmology ManagementCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 2Mitomycin C increases corneal haze after corneal crosslinking - 2 year(s) ago
Shady Awwad, MD, discusses how the application of mitomycin C after corneal crosslinking does not prevent development of corneal haze after the procedure and actually contributes to development of more corneal haze.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Application of mitomycin C after #corneal crosslinking actually contributes to the development of more corneal haze. More: https://t.co/CJ4xUQtWM0 #Ophthalmology #AAO #cornea @AUBMC_Official #AAO2021 https://t.co/253lMrUVVd
-
-
Mashup Score: 0The effects of corneal cross linking on preventing and treating progressive keratoconus - 2 year(s) ago
Philip Dockery, MD, MPH, discusses his paper “Corneal cross linking for progressive keratoconus, a retrospective analysis of 515 consecutive eyes,” with Ophthalmology Times’ David Hutton.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
VIDEO: The effects of #corneal cross linking on preventing and treating progressive #keratoconus WATCH: https://t.co/L1FmaFMf16 #Ophthalmology #ASCRS2022 #ASCRS22 #Clinical #ClinicalTrial #Cornea https://t.co/YVGZBlKfxv
-
-
Mashup Score: 0
The study evaluates three separate cases, each which experiences irreversible changes in their corneal structure caused by challenges in getting timely treatment due to various reasons, including insurance, lost to follow up, and the coronavirus pandemic.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Study: #Keratoconus patients experience challenges in getting timely #corneal #crosslinking that has led to permanent changes in their corneal structure Watch here: https://t.co/Vi1kcrkPrS #Ophthalmology #Cornea #OphthoTwitter https://t.co/F5v8baRG3C
-
-
Mashup Score: 0Researchers pioneer technology that leads successful clinical trial to treat dry eye disease - 2 year(s) ago
A team of investigators at the Texas Tech University Health Sciences Center have developed a technology derived from corneal epithelial stem cells to improve outcomes for DED patients.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Investigators @TTUHSC have developed a technology derived from #corneal epithelial stem cells to improve outcomes for #DryEyeDisease patients Learn more: https://t.co/yNdIh7433w #Ophthalmology #Cornea #DryEye #DED https://t.co/U9O76cDbHf
-
-
Mashup Score: 2Mitomycin C increases corneal haze after corneal crosslinking - 2 year(s) ago
Shady Awwad, MD, discusses how the application of mitomycin C after corneal crosslinking does not prevent development of corneal haze after the procedure and actually contributes to development of more corneal haze.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Application of mitomycin C after #corneal crosslinking actually contributes to the development of more corneal haze, according to new research presented at #AAO2021. Read more: https://t.co/5z7O0FPcZJ #Ophthalmology #AAO #cornea @AUBMC_Official @aao_ophth https://t.co/yfCDhwnCEr
-
-
Mashup Score: 1
Results from Aurion Biotech’s IOTA trial reveals that a corneal endothelial cell therapy showed improvements in visual acuity and central corneal thickness, according to a team of Japanese investigators.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Landmark treatment: #CellTherapy advances options for #corneal endothelial disease More here: https://t.co/kfhplQLLq6 #Ophthalmology #Cornea @AurionBiotech https://t.co/tmICr0DEIv
-
-
Mashup Score: 1
Results from Aurion Biotech’s IOTA trial reveals that a corneal endothelial cell therapy showed improvements in visual acuity and central corneal thickness, according to a team of Japanese investigators.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Landmark treatment: #CellTherapy advances options for #corneal endothelial disease More: https://t.co/3IWg3OXsug #Ophthalmology #Cornea @AurionBiotech https://t.co/ml9qCDM91P
-
-
Mashup Score: 5Mitomycin C increases corneal haze after corneal crosslinking - 2 year(s) ago
Shady Awwad, MD, discusses how the application of mitomycin C after corneal crosslinking does not prevent development of corneal haze after the procedure and actually contributes to development of more corneal haze.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Application of mitomycin C after #corneal crosslinking actually contributes to the development of more corneal haze, according to new research presented at #AAO2021. Read more: https://t.co/2CpV95yF9I #Ophthalmology #AAO #cornea @AUBMC_Official @aao_ophth https://t.co/f1mDGEejsk
-
-
Mashup Score: 5
Results from Aurion Biotech’s IOTA trial reveals that a corneal endothelial cell therapy showed improvements in visual acuity and central corneal thickness, according to a team of Japanese investigators.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Landmark treatment: #CellTherapy advances options for #corneal endothelial disease More here: https://t.co/57hHx0XzzK #Ophthalmology #Cornea @AurionBiotech https://t.co/7ql0tFTxq2
-
CEO Greg Kunst @gdk62 of @AurionBiotech discusses the company’s first candidate, AURN001, a patented cell therapy treatment for corneal endothelial disease. Read the full article at https://t.co/k8ukLSoJRB. #Ophthalmology #Cornea #corneal #celltherapy #eyedisease https://t.co/qbepKv70Yi